These results indicate that VAFs for TP53 L145P reflect a copy-neutral loss of heterozygosity for chromosome 17p (chr17p LOH), which occurred early in the tumor’s evolution (but after the L145P point mutation). The gene discussed is TP53; the disease is neoplasm.